Activin a predicts left ventricular remodeling and mortality in patients with ST-Elevation myocardial infarction

Jeng Feng Lin, Shun Yi Hsu, Ming Sheng Teng, Semon Wu, Chien An Hsieh, Shih Jung Jang, Chih Jen Liu, Hsuan Li Huang, Yu Lin Ko*

*此作品的通信作者

研究成果: 期刊稿件文章同行評審

13 引文 斯高帕斯(Scopus)

摘要

Background: Activin A levels increase in a variety of heart diseases including ST-elevation myocardial infarction (STEMI). The aim of this study is to investigate whether the level of activin A can be beneficial in predicting left ventricular remodeling, heart failure, and death in patients with ST-elevation myocardial infarction (STEMI). Methods:We enrolled 278 patients with STEMIwho had their activin A levels measured on day 2 of hospitalization. Echocardiographic studies were performed at baseline and were repeated 6 months later. Thereafter, the clinical events of these patients were followed for a maximum of 3 years, including all-cause death and readmission for heart failure. Results: During hospitalization, higher activin A level was associated with higher triglyceride level, lower left ventricular ejection fraction (LVEF), and lower left ventricular end diastolic ventricular volume index (LVEDVI) in multivariable linear regression model. During follow-up, patients with activin A levels > 129 pg/ml had significantly lower LVEF, and higher LVEDVI at 6 months. Kaplan-Meier survival curves showed that activin A level > 129 pg/ml was a predictor of all-cause death (p = 0.022), but not a predictor of heart failure (p = 0.767). Conclusions: Activin A level > 129 pg/ml predicts worse left ventricular remodeling and all-cause death in STEMI.

原文英語
頁(從 - 到)420-427
頁數8
期刊Acta Cardiologica Sinica
32
發行號4
DOIs
出版狀態已出版 - 07 2016
對外發佈

文獻附註

Publisher Copyright:
© 2016, Republic of China Society of Cardiology. All rights reserved.

指紋

深入研究「Activin a predicts left ventricular remodeling and mortality in patients with ST-Elevation myocardial infarction」主題。共同形成了獨特的指紋。

引用此